PTH suppression by calcitriol does not predict off‐target actions in experimental CKD

PTH suppression by calcitriol does not predict off‐target actions in experimental CKD

Abstract Vitamin D receptor agonist (VDRA) therapy for PTH suppression is a mainstay for patients with severe CKD. Calcitriol (1,25‐(OH)2D3) is a former first‐line VDRA in CKD treatment. However, a consequence of its use in CKD is accelerated vascular calcification (VC). An experimental CKD model wa...

Full description

Saved in:
Bibliographic Details
Main Authors: Bruno A. Svajger (Author), Cynthia M. Pruss (Author), Kimberly J. Laverty (Author), Jason G. E. Zelt (Author), Glenville Jones (Author), Martin Kaufmann (Author), Martin Petkovich (Author), Rachel M. Holden (Author), Michael A. Adams (Author)
Format: Book
Published: Wiley, 2020-06-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items